BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25777533)

  • 1. Differential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis.
    Boonk SE; Çetinözman F; Vermeer MH; Jansen PM; Willemze R
    J Cutan Pathol; 2015 Sep; 42(9):604-9. PubMed ID: 25777533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of programmed death-1 in skin biopsies of benign inflammatory vs. lymphomatous erythroderma.
    Çetinözman F; Jansen PM; Willemze R
    Br J Dermatol; 2014 Sep; 171(3):499-504. PubMed ID: 24601935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome.
    Ortonne N; Le Gouvello S; Mansour H; Poillet C; Martin N; Delfau-Larue MH; Leroy K; Farcet JP; Bagot M; Bensussan A
    J Invest Dermatol; 2008 Feb; 128(2):465-72. PubMed ID: 17703174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOX expression in different subtypes of cutaneous lymphoma.
    Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases.
    Klemke CD; Booken N; Weiss C; Nicolay JP; Goerdt S; Felcht M; Géraud C; Kempf W; Assaf C; Ortonne N; Battistella M; Bagot M; Knobler R; Quaglino P; Arheiliger B; Santucci M; Jansen P; Vermeer MH; Willemze R
    Br J Dermatol; 2015 Jul; 173(1):93-105. PubMed ID: 25864856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma.
    Sentis HJ; Willemze R; Scheffer E
    J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic diagnosis of lymphomatous versus inflammatory erythroderma: a morphologic and phenotypic study on 47 skin biopsies.
    Ram-Wolff C; Martin-Garcia N; Bensussan A; Bagot M; Ortonne N
    Am J Dermatopathol; 2010 Dec; 32(8):755-63. PubMed ID: 20559121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of morphometry on blood lymphocytes in erythrodermic actinic reticuloid.
    Preesman AH; Schrooyen SJ; Toonstra J; van der Putte SC; Rademakers LH; Willemze R; van Vloten WA
    Arch Dermatol; 1995 Nov; 131(11):1298-303. PubMed ID: 7503574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-Sézary erythroderma evolving to Sézary syndrome. A report of seven cases.
    Buechner SA; Winkelmann RK
    Arch Dermatol; 1983 Apr; 119(4):285-91. PubMed ID: 6220677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
    Fierro MT; Novelli M; Quaglino P; Comessatti A; Fava P; Ortoncelli M; Ponti R; Bernengo MG
    Dermatology; 2008; 216(3):213-21. PubMed ID: 18182812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides.
    Cetinözman F; Jansen PM; Vermeer MH; Willemze R
    Arch Dermatol; 2012 Dec; 148(12):1379-85. PubMed ID: 23247480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study.
    Sigurdsson V; Toonstra J; Bihari IC; Bruijnzeel-Koomen CA; van Vloten WA; Thepen T
    J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actinic reticuloid simulating Sézary syndrome. Report of two cases.
    Toonstra J; van Weelden H; Gmelig Meyling FH; van der Putte SC; Schiere SI; Baart de la Faille H
    Arch Dermatol Res; 1985; 277(3):159-66. PubMed ID: 3160309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.
    Mangold AR; Thompson AK; Davis MD; Saulite I; Cozzio A; Guenova E; Hodak E; Amitay-Laish I; Pujol RM; Pittelkow MR; Gniadecki R
    J Am Acad Dermatol; 2017 Oct; 77(4):719-727. PubMed ID: 28709694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4(+)  CD8(-) phenotype.
    Schrader AM; Jansen PM; Willemze R
    Br J Dermatol; 2016 Aug; 175(2):382-6. PubMed ID: 26931394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.
    Moy AP; Murali M; Kroshinsky D; Duncan LM; Nazarian RM
    JAMA Dermatol; 2015 Jul; 151(7):753-60. PubMed ID: 25760640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic criteria in Sézary's syndrome: a multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma.
    Willemze R; van Vloten WA; Hermans J; Damsteeg MJ; Meijer CJ
    J Invest Dermatol; 1983 Nov; 81(5):392-7. PubMed ID: 6226746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome.
    Fierro MT; Comessatti A; Quaglino P; Ortoncelli M; Osella Abate S; Ponti R; Novelli M; Bernengo MG
    Dermatology; 2006; 213(4):284-92. PubMed ID: 17135733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.
    Luherne C; Menguy S; Ferte T; Beylot-Barry M; Seneschal J; Milpied B; Vial JP; Gros A; Amintas S; Vergier B; Pham-Ledard A
    Acta Derm Venereol; 2022 Sep; 102():adv00773. PubMed ID: 35758515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Sézary syndrome--an erythrodermic T-cell-lymphoma].
    Haustein UF; Gast W; Schippel K; Schippel G; Rytter M
    Z Gesamte Inn Med; 1979 Jan; 34(2):72-8. PubMed ID: 154782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.